Lilly's Zepbound price cuts ranged from $50 to $100, depending on the dosage, for consumers who pay cash via the drugmaker's ...

Eli Lilly and Co. is cutting the price for introductory doses of its weight-loss drug Zepbound again, as competition heats up ...

The WHO issued guideline on the use of GLP-1 therapies for obesity, conditionally recommending them as part of long-term ...

In the early November announcement of its agreement with the government, Lilly pledged to reduce the self-pay price of ...

Lilly drops Zepbound single-dose vial prices on LillyDirect, offering lower costs and more access options for patients with a valid prescription.

The FTSE 100 index closed down 17.98 points, 0.2%, at 9,702.53. The FTSE 250 ended down 144.49 points, 0.7%, at 22,020.68, ...

Page lesson plan / 2-page mini-lesson - Ozempic 2.0 - Handouts, online activities, speed reading, dictation, mp3... current events.

Novo misses in Alzheimer's trial; Insurer shares rise on report Trump will unveil health policy proposal; Bayer’s stroke drug succeeds in late-stage trial.

PEZ celebrates Thanksgiving with gratitude for the 2025 cycling season: Pogačar's dominance, van der Poel's brilliance, ...

The Indianapolis-based drugmaker said the coverage would be administered by third-party administrators to provide employers “transparent, flexible cost-sharing options” for their workers.

The FTSE 100 index closed down 17.98 points, 0.2%, at 9,702.53. The FTSE 250 ended down 144.49 points, 0.7%, at 22,020.68, and the AIM All-Share closed up 0.71 points, 0.1%, at 754.79.